Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
NRXP
NRXP
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
NRXP News
NRx Pharmaceuticals Presents Efficacy of IV Ketamine for Depression Treatment
Jun 05 2026
Newsfilter
NRx Pharmaceuticals Closes $22.3 Million Public Offering
Jun 04 2026
Newsfilter
Biotech Stocks Pre-Market Trading Insights
Jun 03 2026
NASDAQ.COM
NRx Pharmaceuticals Announces Pricing of Public Offering
Jun 03 2026
seekingalpha
NRx Pharmaceuticals Proposes Underwritten Public Offering
Jun 03 2026
NASDAQ.COM
NRx Pharmaceuticals Plans Underwritten Public Offering of Common Stock
Jun 02 2026
seekingalpha
EMOCARE: First Passive Monitoring Tool for Depression Launched
May 28 2026
Newsfilter
NRx Deploys AI-Powered TMS System in Florida Clinic
May 27 2026
Newsfilter
Multiple Companies See Significant Stock Price Gains
May 27 2026
NASDAQ.COM
NRx Pharmaceuticals: Significant Upside Potential in Ketamine Market
May 24 2026
Yahoo Finance
Biotech Investment Environment Improves
May 20 2026
Fool
Analysis of Biotech Companies' Prospects
May 20 2026
NASDAQ.COM
NRx Pharmaceuticals Q1 2026 Earnings Call Insights
May 18 2026
seekingalpha
NRx Pharmaceuticals Q1 Operational Highlights and FDA Progress
May 18 2026
Newsfilter
NRx Pharmaceuticals Reports Q1 Earnings Results
May 18 2026
seekingalpha
NRx Pharmaceuticals Receives FDA Clearance for Depression Clinical Trial
May 07 2026
Newsfilter
Show More News
